BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 6:48:00 PM | Browse: 339 | Download: 258
Publication Name World Journal of Cardiology
Manuscript ID 2830
Country of Manuscript Source United States
Received
2013-03-18 09:35
Peer-Review Started
2013-03-20 08:30
To Make the First Decision
2013-04-03 09:14
Return for Revision
2013-04-15 16:24
Revised
2013-04-16 07:47
Second Decision
2013-04-18 16:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-04-19 06:12
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-05-23 15:12
Publish the Manuscript Online
2013-05-25 21:15
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Cardiac and Cardiovascular Systems
Manuscript type Editorial
Article Title Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics
Manuscript Source Invited Manuscript
All Author List Wilbert S Aronow
Funding Agency and Grant Number
Correspondence To Wilbert S Aronow, MD, FACC, FAHA, Professor of Medicine, Division of Cardiology, Department of Medicine, Westchester Medical Center/New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, United States. wsaronow@aol.com
Keywords Diabetes mellitus; Blood pressure; Hemoglobin A1c; Serum low-density lipoprotein cholesterol; Statins; Lipid-lowering drugs
Core Tip 2013 guidelines state that a reasonable hemoglobin A1c goal for diabetics is less than 7.0% a hemoglobin A1c level less than 8.0% may be appropriate for patients with a history of severe hypoglycemia, limited life expectancy, advanced macrovascular and microvascular complications, and extensive comorbidities. The systolic blood pressure in most diabetics with hypertension should be reduced to less than 140 mmHg. Diabetics at high risk for cardiovascular events should have their serum low-density lipoprotein (LDL) cholesterol lowered to less than 70 mg/dL with statins. Lower-risk diabetics should have their serum LDL cholesterol reduced to less than 100 mg/dL. Combination therapy of a statin with either a fibrate or niacin is not recommended.
Publish Date 2013-05-25 21:15
Citation Aronow WS. Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics. World J Cardiol 2013; 5(5): 119-123
Url http://www.wjgnet.com/1949-8462/full/v5/i5/119.htm
DOI http://dx.doi.org/10.4330/wjc.v5.i5.119
Full Article (PDF) WJC-5-119.pdf
Manuscript File 2830-Review.doc
Answering Reviewers 2830-Answering reviewers.pdf
Copyright License Agreement 2830-Copyright assignment.pdf
Peer-review Report 2830-Peer reviews.pdf
Scientific Editor Work List 2830-Scientific editor work list.doc